|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
Agmatine inhibits the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]; dorsomorphin inhibits the reaction [Agmatine inhibits the reaction [Palmitic Acid results in decreased phosphorylation of AKT1 protein]] |
CTD |
PMID:35747990 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
App |
amyloid beta precursor protein |
decreases abundance multiple interactions |
ISO |
APP protein results in decreased abundance of Agmatine Agmatine inhibits the reaction [APP protein results in decreased expression of BDNF protein]; Agmatine inhibits the reaction [APP protein results in decreased expression of MME protein]; Agmatine inhibits the reaction [APP protein results in increased expression of IL6 protein]; Agmatine inhibits the reaction [APP protein results in increased expression of MAPT protein]; Agmatine inhibits the reaction [APP protein results in increased expression of TNF protein] |
CTD |
PMID:32522471 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
Agmatine inhibits the reaction [APP protein results in decreased expression of BDNF protein] |
CTD |
PMID:32522471 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
ISO |
Agmatine inhibits the reaction [Palmitic Acid results in decreased expression of EDN1 protein] |
CTD |
PMID:35747990 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ednra |
endothelin receptor type A |
multiple interactions |
ISO |
Agmatine inhibits the reaction [Palmitic Acid results in decreased expression of EDNRA protein] |
CTD |
PMID:35747990 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
Agmatine inhibits the reaction [Morphine results in increased expression of FOSB protein] |
CTD |
PMID:15899480 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
ISO |
Agmatine inhibits the reaction [MBP protein results in increased expression of GFAP protein]; NOS2 gene mutant form promotes the reaction [Agmatine inhibits the reaction [MBP protein results in increased expression of GFAP protein]] |
CTD |
PMID:24070732 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
multiple interactions |
EXP |
Agmatine inhibits the reaction [Morphine results in increased expression of GRIN1 protein] |
CTD |
PMID:20950603 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
Agmatine inhibits the reaction [Rotenone results in increased expression of IL1B protein] |
CTD |
PMID:30001633 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Agmatine inhibits the reaction [APP protein results in increased expression of IL6 protein]; Agmatine inhibits the reaction [Valproic Acid results in increased expression of IL6 protein] |
CTD |
PMID:30273971 PMID:32522471 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
ISO |
Agmatine inhibits the reaction [APP protein results in increased expression of MAPT protein] |
CTD |
PMID:32522471 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mbp |
myelin basic protein |
multiple interactions |
ISO |
Agmatine inhibits the reaction [MBP protein results in increased expression of GFAP protein]; Agmatine inhibits the reaction [MBP protein results in increased expression of TFRC protein]; NOS2 gene mutant form promotes the reaction [Agmatine inhibits the reaction [MBP protein results in increased expression of GFAP protein]] |
CTD |
PMID:24070732 |
|
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mme |
membrane metallo-endopeptidase |
multiple interactions |
ISO |
Agmatine inhibits the reaction [APP protein results in decreased expression of MME protein] |
CTD |
PMID:32522471 |
|
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Agmatine inhibits the reaction [Valproic Acid results in increased expression of NOS2 protein]; NOS2 gene mutant form promotes the reaction [Agmatine inhibits the reaction [MBP protein results in increased expression of GFAP protein]] |
CTD |
PMID:24070732 PMID:30273971 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions |
ISO |
Agmatine inhibits the reaction [Palmitic Acid results in increased activity of and results in decreased phosphorylation of NOS3 protein]; dorsomorphin inhibits the reaction [Agmatine inhibits the reaction [Palmitic Acid results in increased activity of and results in decreased phosphorylation of NOS3 protein]] |
CTD |
PMID:35747990 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Agmatine inhibits the reaction [Valproic Acid results in increased expression of RELA protein] |
CTD |
PMID:30273971 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Slc47a1 |
solute carrier family 47 member 1 |
multiple interactions |
ISO |
Agmatine inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:22419765 |
|
NCBI chr10:46,034,115...46,088,617
Ensembl chr10:46,034,122...46,087,637
|
|
G |
Slc47a2 |
solute carrier family 47 member 2 |
multiple interactions |
ISO |
Agmatine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:22419765 |
|
NCBI chr10:45,990,806...46,033,937
Ensembl chr10:45,991,095...46,033,904
|
|
G |
Tfrc |
transferrin receptor |
multiple interactions |
ISO |
Agmatine inhibits the reaction [MBP protein results in increased expression of TFRC protein] |
CTD |
PMID:24070732 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
EXP |
Agmatine inhibits the reaction [Morphine results in increased expression of TH protein] |
CTD |
PMID:15541421 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
Agmatine inhibits the reaction [APP protein results in increased expression of TNF protein]; Agmatine inhibits the reaction [Valproic Acid results in increased expression of TNF protein] Agmatine inhibits the reaction [Rotenone results in increased expression of TNF protein] |
CTD |
PMID:30001633 PMID:30273971 PMID:32522471 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|